Published in Antimicrob Agents Chemother on March 01, 1992
Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev (2007) 3.18
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother (1999) 1.38
Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev (2013) 1.37
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group. Antimicrob Agents Chemother (1997) 0.76
An evaluation of outcome from intensive care in major medical centers. Ann Intern Med (1986) 5.41
Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother (1988) 5.26
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals. J Clin Microbiol (1988) 1.63
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. J Antimicrob Chemother (1990) 1.33
APACHE II score and abdominal sepsis. A prospective study. Arch Surg (1988) 1.22
Surgical infection stratification system for intra-abdominal infection. Multicenter trial. Arch Surg (1985) 1.14
Perforated and gangrenous appendicitis: an analysis of antibiotic failures. J Infect Dis (1983) 1.13
Design and conduct of antibiotic trials. A report of the Scientific Studies Committee of the Surgical Infection Society. Arch Surg (1987) 1.02
Stratified outcome comparison of clindamycin-gentamicin vs chloramphenicol-gentamicin for treatment of intra-abdominal sepsis. Arch Surg (1985) 0.84
Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniques. Clin Ther (1988) 0.83
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science (2001) 8.14
Variations in breast cancer management between a teaching and a non-teaching district. Eur J Cancer (1992) 5.54
Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 3.87
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Do general practitioners know when living wills are legal? J R Coll Physicians Lond (1998) 3.39
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Soc Sci Med (1987) 2.69
Cefoxitin inactivation by Bacteroides fragilis. Antimicrob Agents Chemother (1983) 2.64
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry (2010) 2.59
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21
Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry (2012) 2.20
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest (2000) 2.08
Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy. Rev Infect Dis (1984) 1.94
Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis (2000) 1.83
Dopamine D4 receptor subtypes and response to clozapine. Lancet (1993) 1.69
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry (2004) 1.60
Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess (2000) 1.59
Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry (1999) 1.59
Nosocomial sepsis associated with interleukin-2. Ann Intern Med (1990) 1.56
Utilisation by homeless people of acute hospital services in London. BMJ (1991) 1.53
Meeting the challenge of genetic advance. BMJ (1998) 1.53
The gene for Darier's disease maps to chromosome 12q23-q24.1. Hum Mol Genet (1993) 1.47
Clinical management of allergic rhinitis - the Allergy Society of South Africa Consensus update. S Afr Med J (2006) 1.40
Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann Intern Med (1978) 1.40
Survival in extreme dryness and DNA-single-strand breaks. Adv Space Res (1992) 1.39
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis (1996) 1.38
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother (1999) 1.38
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. J Antimicrob Chemother (1990) 1.33
Monoamine oxidase A gene and bipolar affective disorder. Am J Hum Genet (1994) 1.28
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28
Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase. Antimicrob Agents Chemother (1990) 1.25
Outcomes of universal antenatal screening for haemoglobinopathies. J Med Screen (1999) 1.25
Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 1.24
Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry (2002) 1.24
Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration. Respir Med (1993) 1.24
Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry (2005) 1.24
The Ov20 protein of the parasitic nematode Onchocerca volvulus. A structurally novel class of small helix-rich retinol-binding proteins. J Biol Chem (1997) 1.22
Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry (2004) 1.21
Two outbreaks of foodborne gastroenteritis caused by a small round structured virus: evidence of prolonged infectivity in a food handler. Lancet (1987) 1.21
Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet (1997) 1.21
Dementia in people with Down's syndrome. Int J Geriatr Psychiatry (2001) 1.20
Imprinting and anticipation. Are they relevant to genetic studies of schizophrenia? Br J Psychiatry (1994) 1.20
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
A surface-associated retinol- and fatty acid-binding protein (Gp-FAR-1) from the potato cyst nematode Globodera pallida: lipid binding activities, structural analysis and expression pattern. Biochem J (2001) 1.16
Pigments of fungi (Macromycetes). Fortschr Chem Org Naturst (1987) 1.16
Audit of direct access cardiac investigations: experience in an inner London Health District. J R Soc Med (1994) 1.14
The meaning, effectiveness and future of social marketing. Obes Rev (2007) 1.13
Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type. Psychol Med (2010) 1.13
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes Brain Behav (2010) 1.10
The relationship between ADHD and key cognitive phenotypes is not mediated by shared familial effects with IQ. Psychol Med (2010) 1.10
Collecting data on cancer. BMJ (1994) 1.09
Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet (1995) 1.09
Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br J Psychiatry (2001) 1.09
Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry (2004) 1.08
Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry (2005) 1.07
Infection in AIDS. Can J Infect Dis (1991) 1.07
The Wellcome trust UK-Irish bipolar affective disorder sibling-pair genome screen: first stage report. Mol Psychiatry (2002) 1.07
Genome-wide association analysis of copy number variation in recurrent depressive disorder. Mol Psychiatry (2011) 1.05
Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.04
Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.04
The ABA-1 allergen of Ascaris lumbricoides: sequence polymorphism, stage and tissue-specific expression, lipid binding function, and protein biophysical properties. Parasitology (2000) 1.04
DNA-strand breaks limit survival in extreme dryness. Orig Life Evol Biosph (1991) 1.03
Estimating the heritability of reporting stressful life events captured by common genetic variants. Psychol Med (2012) 1.01
Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry (2002) 1.00
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
Recent advances in obstetrics. Figures on screening for Down's syndrome are inaccurate. BMJ (1996) 0.99
Outer-membrane proteins pattern and detection of beta-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil. Int J Antimicrob Agents (2000) 0.99
Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.99
Cervical screening for women with learning disability. Concerted effort is needed to ensure these women use preventive services. BMJ (1999) 0.99
Depressive disorder moderates the effect of the FTO gene on body mass index. Mol Psychiatry (2011) 0.98
Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2007) 0.98
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci Lett (2012) 0.98
Autosome search for schizophrenia susceptibility genes in multiply affected families. Mol Psychiatry (1999) 0.97
Paget's disease in New Zealand: evidence for declining prevalence. Bone (2002) 0.96
Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy. Drug Intell Clin Pharm (1986) 0.95
Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression. Psychol Med (2011) 0.95
The Social Communication Questionnaire in a sample of the general population of school-going children. Ir J Med Sci (2008) 0.95
Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr Genet (2001) 0.94
Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry. Radiat Res (1992) 0.94
Relationships of perceived stress to coping, attachment and social support among HIV-positive persons. AIDS Care (2000) 0.94
A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD). Neurobiol Aging (2009) 0.94
Analysis of breast milk to assess exposure to chlorinated contaminants in Kazakstan: PCBs and organochlorine pesticides in southern Kazakstan. Environ Health Perspect (1997) 0.94
Constituents of Agaricus xanthodermus Genevier: the first naturally endogenous azo compound and toxic phenolic metabolites. Z Naturforsch C (1985) 0.94
Genome-wide linkage analysis of 972 bipolar pedigrees using single-nucleotide polymorphisms. Mol Psychiatry (2011) 0.93
Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Psychiatry (2002) 0.93
No evidence for a pseudoautosomal locus for schizophrenia. Linkage analysis of multiply affected families. Br J Psychiatry (1992) 0.93
Dopaminergic genotype biases spatial attention in healthy children. Mol Psychiatry (2007) 0.93
Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm (Vienna) (2008) 0.92
Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Mol Psychiatry (2005) 0.92
Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry (2003) 0.92
Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry (2000) 0.92
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet (2007) 0.92